يعرض 1 - 8 نتائج من 8 نتيجة بحث عن '"venom immunotherapy (VIT)"', وقت الاستعلام: 0.35s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
    Academic Journal
  6. 6
    Academic Journal
  7. 7

    المصدر: The Journal of Allergy and Clinical Immunology: In Practice
    The Journal of Allergy and Clinical Immunology. in Practice

    مصطلحات موضوعية: Cost-Benefit Analysis, Health Status, Self Administration, allergy immunotherapy, American College of Allergy, Asthma and Immunology, ACAAI, venom immunotherapy, VIT, 0302 clinical medicine, Health care, Pandemic, health outcomes, Medicine, Immunology and Allergy, Severe acute respiratory syndrome coronavirus 2, SARS-CoV-2, 030212 general & internal medicine, emergency department, ED, Child, systemic reactions, SR, health care economics and organizations, SCIT, subcutaneous immunotherapy, allergic rhinitis, AR, coronavirus disease 2019, COVID-19, quality adjusted life years, cost-effectiveness analysis, willingness to pay, WTP, quality adjusted life years, QALY, incremental cost-effectiveness ratio, ICER, Cost-effectiveness analysis, Middle Aged, simulation, Markov Chains, Child, Preschool, epinephrine auto-injectors, systemic reaction to immunotherapy, Coronavirus Infections, Incremental cost-effectiveness ratio, Adult, Allergen immunotherapy, medicine.medical_specialty, home venom immunotherapy, HOMVIT, Adolescent, Pneumonia, Viral, home allergen immunotherapy self-administration, HITSA, Article, Betacoronavirus, Young Adult, 03 medical and health sciences, fatality, Net Monetary Benefit, NMB, anaphylaxis, and Canadian Society of Allergy and Clinical Immunology, CSACI, Humans, Epinephrine autoinjector, epinephrine, Intensive care medicine, Pandemics, allergic rhinitis, American Academy of Allergy, Asthma and Immunology, AAAAI, SARS-CoV-2, business.industry, systemic reactions to immunotherapy, SRIT, COVID-19, Allergen immunotherapy, AIT, allergy, Health Literacy, Quality-adjusted life year, World Health Organization, WHO, 030228 respiratory system, venom immunotherapy, Desensitization, Immunologic, economic outcomes, Relative risk, epinephrine auto-injector, EAI, business

  8. 8